Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021

Anavex Life Sciences to Participate in the BTIG Virtual Biotechnology Conference 2021   NEW YORK – August 4, 2021 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central…